Company Filing History:
Years Active: 2003
Title: Aharona Glatman-Freedman: Innovator in Monoclonal Antibodies
Introduction
Aharona Glatman-Freedman is a notable inventor based in Irvington, NY (US). He has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies for the detection of mycobacterium tuberculosis. His work has implications for both diagnostics and treatment in infectious diseases.
Latest Patents
Glatman-Freedman holds a patent for "Monoclonal antibodies to mycobacterium tuberculosis and a modified ELISA assay." This invention provides monoclonal antibodies, hybridoma cell lines that produce these antibodies, and methods for their use in detecting mycobacterium tuberculosis. The modified ELISA assay developed in this patent enhances the detection of microorganisms, showcasing the innovative approach taken by Glatman-Freedman in addressing public health challenges.
Career Highlights
Aharona Glatman-Freedman is affiliated with the Albert Einstein College of Medicine, where he has contributed to research and development in the field of immunology. His work has been instrumental in advancing the understanding and detection of tuberculosis, a disease that continues to pose a significant health threat globally.
Collaborations
Glatman-Freedman has collaborated with notable figures in his field, including Arturo Casadevall. These partnerships have fostered advancements in research and have led to significant contributions to the scientific community.
Conclusion
Aharona Glatman-Freedman is a distinguished inventor whose work in monoclonal antibodies has the potential to improve diagnostic methods for tuberculosis. His contributions to the field of immunology are invaluable and continue to influence research and healthcare practices.